ADH1B promotes mesothelial clearance and ovarian cancer infiltration.

Oncotarget 2018 May 18;9(38):25115-25126. Epub 2018 May 18.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Primary debulking surgery followed by adjuvant chemotherapy is the standard treatment for ovarian cancer. Residual disease after primary surgery is associated with poor patient outcome. Previously, we discovered ADH1B to be a molecular biomarker of residual disease. In the current study, we investigated the functional role of ADH1B in promoting ovarian cancer cell invasiveness and contributing to residual disease. We discovered that ADH1B overexpression leads to a more infiltrative cancer cell phenotype, promotes metastasis, increases the adhesion of cancer cells to mesothelial cells, and increases extracellular matrix degradation. Live cell imaging revealed that ADH1B-overexpressing cancer cells efficiently cleared the mesothelial cell layer compared to control cells. Moreover, gene array analysis revealed that ADH1B affects several pathways related to the migration and invasion of cancer cells. We also discovered that hypoxia increases ADH1B expression in ovarian cancer cells. Collectively, these findings indicate that ADH1B plays an important role in the pathways that promote ovarian cancer cell infiltration and may increase the likelihood of residual disease following surgery.

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25344DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982754PMC
May 2018
5 Reads

Publication Analysis

Top Keywords

ovarian cancer
20
residual disease
16
cancer cells
16
cancer cell
12
cancer
9
discovered adh1b
8
adh1b
7
cells
6
cell
5
ovarian
5
revealed adh1b-overexpressing
4
imaging revealed
4
live cell
4
degradation live
4
cell imaging
4
adh1b overexpression
4
efficiently cleared
4
cleared mesothelial
4
cells efficiently
4
matrix degradation
4

Similar Publications